Trial Profile
Safety Study of OPC-12759 Ophthalmic Solution
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Dec 2021
Price :
$35
*
At a glance
- Drugs Rebamipide (Primary)
- Indications Dry eyes
- Focus Adverse reactions
- Sponsors Otsuka Pharmaceutical
- 19 Apr 2014 New trial record